VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 107 filers reported holding VAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $25,941,643 | +701.4% | 343,552 | +625.0% | 0.04% | +740.0% |
| Q1 2024 | $3,237,074 | +128.0% | 47,388 | +109.7% | 0.01% | +150.0% |
| Q4 2023 | $1,419,468 | +1261.5% | 22,603 | +1005.3% | 0.00% | – |
| Q3 2023 | $104,254 | +0.6% | 2,045 | -1.4% | 0.00% | – |
| Q2 2023 | $103,625 | -20.3% | 2,075 | -40.2% | 0.00% | – |
| Q1 2023 | $130,018 | -36.4% | 3,469 | -18.7% | 0.00% | – |
| Q4 2022 | $204,506 | +96.6% | 4,265 | -2.2% | 0.00% | – |
| Q3 2022 | $104,000 | +316.0% | 4,359 | +275.5% | 0.00% | – |
| Q2 2022 | $25,000 | – | 1,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $59,882,148 | 46.04% |
| Darwin Global Management, Ltd. | 2,080,946 | $163,916,116 | 19.07% |
| RA Capital Management | 8,203,754 | $619,465,465 | 8.19% |
| ACUTA CAPITAL PARTNERS, LLC | 110,400 | $8,336,304 | 7.02% |
| COMMODORE CAPITAL LP | 1,305,000 | $98,540,550 | 6.73% |
| Saturn V Capital Management LP | 215,680 | $16,285,997 | 6.15% |
| Cormorant Asset Management, LP | 1,100,000 | $83,061,000 | 4.80% |
| Kynam Capital Management, LP | 753,240 | $56,877,152 | 4.39% |
| Novo Holdings A/S | 950,000 | $71,734,500 | 4.16% |
| Frazier Life Sciences Management, L.P. | 1,039,405 | $78,485,472 | 3.67% |